I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Skoulidis, Ferdinandos
82
results:
Search for persons
X
Format
Online (82)
Mediatypes
Articles (Online) (30)
OpenAccess-fulltext (52)
Sorted by: Relevance
Sorted by: Year
?
1
Real-World Efficacy and Safety of Amivantamab for EGFR-Muta..:
Wang, Kaiwen
;
Du, Robyn
;
Myall, Nathaniel J.
...
Journal of Thoracic Oncology. 19 (2024) 3 - p. 500-506 , 2024
Link:
https://doi.org/10.1016/..
?
2
Brief Report: Comprehensive Clinicogenomic Profiling of Sma..:
Zhang, Bingnan
;
Lewis, Whitney
;
Stewart, C. Allison
...
JTO Clinical and Research Reports. 5 (2024) 2 - p. 100623 , 2024
Link:
https://doi.org/10.1016/..
?
3
Mutational characteristics and clinical outcomes for lung a..:
Pan, Kelsey
;
Owens, Jennifer
;
Elamin, Yasir
...
Journal of Thoracic Oncology. , 2024
Link:
https://doi.org/10.1016/..
?
4
MCT4-dependent lactate secretion suppresses antitumor immun..:
Qian, Yu
;
Galan-Cobo, Ana
;
Guijarro, Irene
...
Cancer Cell. 41 (2023) 7 - p. 1363-1380.e7 , 2023
Link:
https://doi.org/10.1016/..
?
5
Irinotecan- vs. Oxaliplatin-Based Doublets in KRASG12C-Muta..:
Formica, Vincenzo
;
Morelli, Cristina
;
Conca, Veronica
...
Cancers. 15 (2023) 11 - p. 3064 , 2023
Link:
https://doi.org/10.3390/..
?
6
Efficacy and clinicogenomic correlates of response to immun..:
Hong, Lingzhi
;
Aminu, Muhammad
;
Li, Shenduo
...
Nature Communications. 14 (2023) 1 - p. , 2023
Link:
https://doi.org/10.1038/..
?
7
Brief Report: Clinical Response, Toxicity, and Resistance M..:
Wang, Kaiwen
;
Du, Robyn
;
Roy-Chowdhuri, Sinchita
...
JTO Clinical and Research Reports. 4 (2023) 8 - p. 100533 , 2023
Link:
https://doi.org/10.1016/..
?
8
Sotorasib versus docetaxel for previously treated non-small..:
de Langen, Adrianus Johannes
;
Johnson, Melissa L
;
Mazieres, Julien
...
The Lancet. 401 (2023) 10378 - p. 733-746 , 2023
Link:
https://doi.org/10.1016/..
?
9
KRAS G12C in advanced NSCLC: Prevalence, co-mutations, and ..:
Lim, Tony Kiat Hon
;
Skoulidis, Ferdinandos
;
Kerr, Keith M.
...
Lung Cancer. 184 (2023) - p. 107293 , 2023
Link:
https://doi.org/10.1016/..
?
10
Nivolumab and ipilimumab with concurrent stereotactic radio..:
Altan, Mehmet
;
Wang, Yan
;
Song, Juhee
...
Journal for ImmunoTherapy of Cancer. 11 (2023) 7 - p. e006871 , 2023
Link:
https://doi.org/10.1136/..
?
11
Long-Term Benefit of Sotorasib in Patients With KRAS G12C–M..:
Dy, Grace K
;
Govindan, Ramaswamy
;
Velcheti, Vamsidhar
...
Future Oncology. 20 (2023) 3 - p. 113-120 , 2023
Link:
https://doi.org/10.2217/..
?
12
Phase I Trial of Definitive Concurrent Chemoradiotherapy an..:
Lin, Steven H
;
Lin, Heather Y
;
Verma, Vivek
...
Cancer Treatment and Research Communications. 30 (2022) - p. 100514 , 2022
Link:
https://doi.org/10.1016/..
?
13
Clinical validation of Guardant360 CDx as a blood-based com..:
Bauml, Joshua M.
;
Li, Bob T.
;
Velcheti, Vamsidhar
...
Lung Cancer. 166 (2022) - p. 270-278 , 2022
Link:
https://doi.org/10.1016/..
?
14
Final efficacy outcomes of atezolizumab with chemoradiation..:
Liu, Yufei
;
Yao, Luyang
;
Kalhor, Neda
...
Lung Cancer. 174 (2022) - p. 112-117 , 2022
Link:
https://doi.org/10.1016/..
?
15
Diminished Efficacy of Programmed Death-(Ligand)1 Inhibitio..:
Ricciuti, Biagio
;
Arbour, Kathryn C.
;
Lin, Jessica J.
...
Journal of Thoracic Oncology. 17 (2022) 3 - p. 399-410 , 2022
Link:
https://doi.org/10.1016/..
1-15